journal articleLitStream CollectionHealth Canada assesses risk of drug interactions with Jakavi2018 Reactions Weeklydoi: 10.1007/s40278-018-52980-6pmid: N/A
journal articleLitStream CollectionPhase III trial of rivaroxaban (Xarelto) prematurely stopped2018 Reactions Weeklydoi: 10.1007/s40278-018-52981-6pmid: N/A
journal articleLitStream CollectionAlzheimer's disease: stroke with antiepilepetic drugs2018 Reactions Weeklydoi: 10.1007/s40278-018-52982-6pmid: N/A
journal articleLitStream CollectionCardiovascular disease with adjuvant endocrine therapy2018 Reactions Weeklydoi: 10.1007/s40278-018-52983-6pmid: N/A
journal articleLitStream CollectionDrug interaction test reduces outpatient visits and costs2018 Reactions Weeklydoi: 10.1007/s40278-018-52984-6pmid: N/A
journal articleLitStream CollectionNews from 19th World Conference on Lung Cancer2018 Reactions Weeklydoi: 10.1007/s40278-018-52985-6pmid: N/A
journal articleLitStream CollectionPharmacovigilance centres: drug safety during pregnancy2018 Reactions Weeklydoi: 10.1007/s40278-018-52986-6pmid: N/A
journal articleLitStream CollectionPPIs increase risks of hepatic encephalopathy and mortality2018 Reactions Weeklydoi: 10.1007/s40278-018-52987-6pmid: N/A
journal articleLitStream CollectionReal-world rates and costs of EGFR-TKI-related adverse events2018 Reactions Weeklydoi: 10.1007/s40278-018-52988-6pmid: N/A
journal articleLitStream CollectionRheumatic immune-related AEs with checkpoint inhibitors2018 Reactions Weeklydoi: 10.1007/s40278-018-52989-6pmid: N/A